Semantic variant primary progressive aphasia (svPPA) can be inheritable. There is a predictable relationship between the pathological substrate and genetic variants in this condition.
Objective
To report a case with svPPA who carried a MAPT gene mutation and to explore clinical differences between svPPA with TDP-43 pathology-related genes and svPPA with tau pathology-related genes.
Methods
Studies reporting svPPA patients with MAPT, TARDBP, GRN, C9orf72, or TBK1 gene mutations were selected from PubMed and China National Knowledge Infrastructure (CNKI). Of the 109 articles from the literature, 31 reports involving 75 cases provided the outcomes of interest.
Results
Along with the new case, 76 patients (43 males and 33 females) were included in this study. Among them, 34 carried MAPT mutations, 15 with TARDBP mutations, 13 with GRN mutations, 8 with C9orf72 expansions, and 6 with TBK1 mutations. The analysis results revealed that the mean age of onset in the tau pathology-related gene mutation group (50.56 ± 7.46 years) was younger than that in the TDP-43 pathology-related gene mutation group (58.19 ± 7.66 years) (p < 0.001). MAPT and TARDBP mutations were more prevalent in the study population, accounting for 44.7% and 19.7%, respectively. Within the MAPT gene mutation population, P301L accounted for 41.2%, while IVS10 + 16C > T accounted for 38.2%. Among the TARDBP gene mutation carriers, I383V accounted for 73.3%.
Conclusions
The onset age in svPPA patients with tau pathology-related gene mutations is younger than in those with TDP-43 pathology-related gene mutations. MAPT variants, specifically P301L and IVS10 + 16C > T, as well as TARDBP I383V variant, may have higher mutation frequency in svPPA.
PremiEPadovaniABorroniB. Frontotemporal lobar degeneration. Adv Exp Med Biol2012; 724: 114–127.
3.
MarshallCRHardyCJDVolkmerA, et al.Primary progressive aphasia: a clinical approach. J Neurol2018; 265: 1474–1490.
4.
RuksenaiteJVolkmerAJiangJ, et al.Primary progressive aphasia: toward a pathophysiological synthesis. Curr Neurol Neurosci Rep2021; 21: 7.
5.
SpinelliEGMandelliMLMillerZA, et al.Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol2017; 81: 430–443.
6.
SnowdenJS. Changing perspectives on frontotemporal dementia: a review. J Neuropsychol2023; 17: 211–234.
7.
Van MosseveldeSEngelborghsSvan der ZeeJ, et al.Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol2018; 14: 363–378.
8.
Gorno-TempiniMLHillisAEWeintraubS, et al.Classification of primary progressive aphasia and its variants. Neurology2011; 76: 1006–1014.
9.
NearyDSnowdenJSGustafsonL, et al.Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology1998; 51: 1546–1554.
10.
XuJXiaYMengM, et al.Clinical features and biomarkers of semantic variant primary progressive aphasia with MAPT mutation. Alzheimers Res Ther2023; 15: 21.
11.
TacikPSanchez-ContrerasMDeTureM, et al.Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy. Neuropathol Appl Neurobiol2017; 43: 200–214.
12.
Borrego-ÉcijaSMorgadoJPalencia-MadridL, et al.Frontotemporal dementia caused by the P301L mutation in the MAPT gene: clinicopathological features of 13 cases from the same geographical origin in Barcelona, Spain. Dement Geriatr Cogn Disord2017; 44: 213–221.
13.
IshizukaTNakamuraMIchibaM, et al.Familial semantic dementia with P301L mutation in the tau gene. Dement Geriatr Cogn Disord2011; 31: 334–340.
14.
BessiVBagnoliSNacmiasB, et al.Semantic dementia associated with mutation V363I in the tau gene. J Neurol Sci2010; 296: 112–114.
15.
RossiGSalviEMehmetiE, et al.Semantic and right temporal variant of FTD: next generation sequencing genetic analysis on a single-center cohort. Front Aging Neurosci2022; 14: 1085406.
16.
DeramecourtVLebertFMaurageCA, et al.Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S. J Alzheimers Dis2012; 31: 741–749.
17.
KobayashiTOtaSTanakaK, et al.A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology. Ann Neurol2003; 53: 133–137.
18.
Pickering-BrownSMRollinsonSDu PlessisD, et al.Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain2008; 131: 721–731.
19.
ShiZLiuSXiangL, et al.Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population. J Hum Genet2016; 61: 1003–1008.
20.
DongLWangJLiuC, et al.Genetic spectrum and clinical heterogeneity of Chinese frontotemporal dementia patients: data from PUMCH Dementia Cohort. J Alzheimers Dis2022; 89: 893–901.
21.
González-SánchezMPuertas-MartínVEsteban-PérezJ, et al.TARDBP Mutation associated with semantic variant primary progressive aphasia, case report and review of the literature. Neurocase2018; 24: 301–305.
22.
RamosEMDokuruDRVan BerloV, et al.Genetic screen in a large series of patients with primary progressive aphasia. Alzheimers Dement2019; 15: 553–560.
23.
FengFWangHLiuJ, et al.Genetic and clinical features of Chinese sporadic amyotrophic lateral sclerosis patients with TARDBP mutations. Brain Behav2021; 11: e2312.
24.
van RooijJMolMOMelhemS, et al.Somatic TARDBP variants as a cause of semantic dementia. Brain2020; 143: 3827–3841.
25.
MolMONijmeijerSWRvan RooijJGJ, et al.Distinctive pattern of temporal atrophy in patients with frontotemporal dementia and the I383V variant in TARDBP. J Neurol Neurosurg Psychiatry2021; 92: 787–789.
26.
RamosEMKorosCDokuruDR, et al.Frontotemporal dementia spectrum: first genetic screen in a Greek cohort. Neurobiol Aging2019; 75: 224.e1–224.e8.
27.
ChenCZhuFXuC, et al.A case with semantic dementia due to GRN gene mutation. Chin J Alzheimers Dis Relat Disord2023; 6: 136–140. Chinese.
28.
MesulamMJohnsonNKrefftTA, et al.Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol2007; 64: 43–47.
29.
ChuMNanHJiangD, et al.Progranulin gene mutations in Chinese patients with frontotemporal dementia: a case report and literature review. J Alzheimers Dis2023; 93: 225–234.
30.
CeramiCMarconeAGalimbertiD, et al.Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia. J Alzheimers Dis2013; 36: 415–420.
31.
WautersEVan MosseveldeSSleegersK, et al.Clinical variability and onset age modifiers in an extended Belgian GRN founder family. Neurobiol Aging2018; 67: 84–94.
32.
PiaceriIPradellaSCupidiC, et al.Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration. J Alzheimers Dis2014; 40: 679–685.
33.
DavionSJohnsonNWeintraubS, et al.Clinicopathologic correlation in PGRN mutations. Neurology2007; 69: 1113–1121.
34.
SaracinoDGéraudieARemesAM, et al.Primary progressive aphasias associated with C9orf72 expansions: another side of the story. Cortex2021; 145: 145–159.
35.
CeramiCMarconeAGalimbertiD, et al.Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9. J Alzheimers Dis2013; 35: 455–462.
36.
SnowdenJSRollinsonSThompsonJC, et al.Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain2012; 135: 693–708.
37.
GalimbertiDFenoglioCSerpenteM, et al.Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry2013; 74: 384–391.
38.
PytelVHernández-LorenzoLTorre-FuentesL, et al.Whole-exome sequencing and C9orf72 analysis in primary progressive aphasia. J Alzheimers Dis2021; 80: 985–990.
39.
Van LangenhoveTvan der ZeeJGijselinckI, et al.Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA Neurol2013; 70: 365–373.
40.
CaroppoPCamuzatADe SeptenvilleA, et al.Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in TBK1 carriers. Alzheimers Dement (Amst)2015; 1: 481–486.
41.
RoytmanMChiangGCGordonML, et al.Multimodality imaging in primary progressive aphasia. AJNR Am J Neuroradiol2022; 43: 1230–1243.
42.
BothaHJosephsKA. Primary progressive aphasias and apraxia of speech. Continuum (Minneap Minn)2019; 25: 101–127.
43.
KimEJKwonJCParkKH, et al.Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia. Neurobiol Aging2014; 35: 1213.e13–17.
44.
TangMGuXWeiJ, et al.Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia. Neurobiol Aging2016; 46: 235.e11–15.
45.
MaoCDongLLiJ, et al.Phenotype heterogeneity and genotype correlation of MAPT mutations in a Chinese PUMCH cohort. J Mol Neurosci2021; 71: 1015–1022.
46.
MooreKMNicholasJGrossmanM, et al.Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol2020; 19: 145–156.
